Adaptive Biotechnologies Corp ADPT on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001478320
0001478320
EIN:
27-0907024
27-0907024
LEI:
(CF Office: 03 Life Sciences)
Business address:
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Phone: 206-659-0067
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Phone: 206-659-0067
Mailing address:
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Category:
Accelerated filer
Accelerated filer
Former names:
- Adaptive TCR Corp - filings through 2011-06-02
Filings:
627 EDGAR filings since December 28, 2009
627 EDGAR filings since December 28, 2009
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 24, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 13, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 12, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 10, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 6, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- February 11, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- March 3, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 7, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 1, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 7, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 26, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 26, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 17, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 17, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 4, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 627 entries
Data source:
CIK0001478320.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
